Recent Updates
Recently added Catalysts

Carboxymethylcellulose Based Lubricant Eye

Phase 3

Dry Eye Syndromes | Small molecule | Ophthalmology |AbbVie Inc.|Last Updated: Apr 16, 2019

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindACTIVE_CONTROLLEDBiomarker
Total Trials1
Total Enrollment315
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01459588Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye DiseasePHASE3 COMPLETED 315Oct 1, 2011Feb 15, 2012Apr 16, 20191 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Change From Baseline in Ocular Surface Disease Index© Questionnaire Score
Baseline, Day 30

The Ocular Surface Disease Index© Questionnaire is a 12-item survey assessing the overall severity of dry eye disease per patient. Each question is rated on a 5-point scale ranging from 0=none of the time to 4=all of the time for a total possible score of 0=No disease to 100=Maximum severity of disease. A negative change from baseline indicates improvement.

Secondary Endpoints
Change From Baseline in Tear Break-up Time
Baseline, Day 30
Change From Baseline in Corneal Staining
Baseline, Day 30
Change From Baseline in Conjunctival Staining
Baseline, Day 30
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingTRIPLE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
Carboxymethylcellulose Based Eye Drop Formulation AEXPERIMENTALCarboxymethylcellulose Based Eye Drop Formulation A (Refresh Optive® Advanced Sensitive Eye Drops) 1-2 drops in each eye as needed, at least 2 times daily for 30 days.
Carboxymethylcellulose Based Eye Drop Formulation BEXPERIMENTALCarboxymethylcellulose Based Eye Drop Formulation B (Refresh Optive® Advanced Eye Drops) 1-2 drops in each eye as needed at least 2 times daily for 30 days.
Carboxymethylcellulose Preservative-Free Lubricant Eye DropsACTIVE_COMPARATORCarboxymethylcellulose Based Preservative-Free Lubricant Eye Drops (Optive® Sensitive Preservative-Free Lubricant Eye Drops) 1-2 drops in each eye as needed at least 2 times daily for 30 days.
Carboxymethylcellulose Based Lubricant Eye DropsACTIVE_COMPARATORCarboxymethylcellulose Based Lubricant Eye Drops (Optive® Lubricant Eye Drops) 1-2 drops in each eye as needed, at least 2 times daily for 30 days.
Interventions
NameTypeDescription
Carboxymethylcellulose Based Eye Drop Formulation ADRUGCarboxymethylcellulose Based Eye Drop Formulation A (Refresh Optive® Advanced Sensitive Eye Drops) 1-2 drops in each eye as needed, at least 2 times daily for 30 days.
Carboxymethylcellulose Based Eye Drop Formulation BDRUGCarboxymethylcellulose Based Eye Drop Formulation B (Refresh Optive® Advanced Eye Drops) 1-2 drops in each eye as needed at least 2 times daily for 30 days.
Carboxymethylcellulose Based Preservative-Free Lubricant Eye DropsDRUGCarboxymethylcellulose Based Preservative-Free Lubricant Eye Drops (Optive® Sensitive Preservative-Free Lubricant Eye Drops) 1-2 drops in each eye as needed at least 2 times daily for 30 days.
Carboxymethylcellulose Based Lubricant Eye DropsDRUGCarboxymethylcellulose Based Lubricant Eye Drops (Optive® Lubricant Eye Drops) 1-2 drops in each eye as needed, at least 2 times daily for 30 days.
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — N/A
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: * Dry eyes * Current use of eye drops for dry eye at least twice daily, on average for at least 3 months Exclusion Criteria: * Cataract, laser-assisted in situ keratomileusis (LASIK), or photorefractive keratectomy (PRK) surgery in the last 12 months * Need to wear contact len...

Countries:United States
Unlock Eligibility Criteria
Competitive Landscape -Myelodysplastic Syndromes 76 trials
Unlock Competitive Intelligence